
Available online at www.sciencedirect.com

Pharmacology & Therapeutics 101 (2004) 39–46

Associate editor: A.L. Morrow

# Recent advances in the neurobiology of alcoholism: the role of adenosine

William S. Mailliard${}^{a,b}$, Ivan Diamond${}^{a,b,c,d,*}$

${}^{a}$Ernest Gallo Clinic and Research Center, University of California, San Francisco, 5858 Horton Street, Suite 200, Emeryville, CA 94608, USA  
${}^{b}$Department of Neurology, University of California, San Francisco, CA 94110, USA  
${}^{c}$Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94110, USA  
${}^{d}$Neuroscience Graduate Program and The Wheeler Center for the Neurobiology of Addiction, University of California, San Francisco, CA 94110, USA  

---

## Abstract

Neuronal responses to alcohol involve several hormone- and neurotransmitter-activated signal transduction pathways. Recent studies suggest that the adenosine A2 receptor (A2) mediates important actions of alcohol. Ethanol inhibits adenosine reuptake, increases extracellular adenosine, and promotes activation of A2. This leads to enhanced cAMP/protein kinase A (PKA) signaling ranging from increases in cAMP to stimulation of cAMP-dependent cAMP response element (CRE)-mediated gene expression. Medium spiny neurons in the striatum/nucleus accumbens (NAc) express A2 and dopamine D2 receptor (D2) on the same cells. Studies in model neuronal cell lines and primary neurons in culture expressing A2 and D2 provide evidence for synergy between ethanol/A2 and D2. Subthreshold concentrations of ethanol or a D2 agonist, without effect separately, synergistically activate cAMP/PKA signaling. Thus, neurons expressing A2 and D2 on the same cells, like in the NAc, are characterized by hypersensitivity to ethanol with a simultaneous activation of dopaminergic signaling. Synergy requires adenosine and appears to be mediated by the release of free $\beta\gamma$ dimers from $G_{i/o}$ via D2 activation. The release of free $\beta\gamma$ has pathophysiological significance in the drinking animal because specific blockade of $\beta\gamma$ signaling in the NAc strikingly reduces voluntary alcohol consumption. These findings suggest that signaling pathways, which regulate synergy between A2 and D2, might contain molecular targets for the prevention and treatment of alcoholism and alcohol abuse.

© 2003 Elsevier Inc. All rights reserved.

**Keywords:** Adenosine; Ethanol; Dopamine; PKA; Synergy; Nucleus accumbens

**Abbreviations:** A2, adenosine A2 receptor; CRE, cAMP response element; CREB, cAMP response element binding protein; D2, dopamine D2 receptor; NAc, nucleus accumbens

---

## Contents

1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .signal transduction pathways, leading to short-term (acute) and long-term (chronic) changes in gene expression and neuronal function (Diamond & McIntire, 2002). Recent evidence from several laboratories, including ours, implicates a direct role for the neuromodulator adenosine in mediating many of the cellular and behavioral responses to ethanol. This review summarizes these studies. For a more extensive discussion of adenosine signaling in the nervous system, see Dunwiddie and Masino (2001), Latini and Pedata (2001), and Ribeiro et al. (2003).

A major hurdle in studying the neurobiology of ethanol has been the lack of a reliable in vitro model system. Therefore, we set out to develop a model cell culture preparation using the neuroblastoma-glioma hybrid cell line NG108-15. These cells were developed originally as a cellular model for morphine addiction (Sharma et al., 1975). Gordon et al. (1986) found that NG108-15 cells displayed cellular correlates of ethanol intoxication, tolerance, and dependence. An initial observation was that acute exposure to ethanol increased cellular cAMP levels (Gordon et al., 1986; Nagy et al., 1989). By contrast, chronic exposure to ethanol resulted in a decrease in cellular cAMP levels due to heterologous desensitization of Gs-coupled receptors (Charness et al., 1988; Mochly-Rosen et al., 1988; Nagy et al., 1989). Thus, ethanol-induced desensitization correlates with a decrease in mRNA and protein levels of the α subunit of Gs (Mochly-Rosen et al., 1988). Once ethanol is removed, receptor-stimulated cAMP production returns to control levels within 48 hr (Gordon et al., 1986). In contrast to ethanol-induced activation of cAMP production in intact cells, ethanol has a negligible effect on adenylyl cyclase (AC) activity in isolated membrane preparations (Harper & Brooker, 1980). This suggested that short-term exposure of NG108-15 cells to ethanol increased the extracellular concentration of a ligand, which stimulates cAMP production via a receptor-mediated mechanism. This ligand proved to be adenosine (Gordon et al., 1986; Nagy et al., 1989, 1990; Sapru et al., 1994).

distinguished by their sensitivity to the transport inhibitor nitrobenzylthioinosine (NBTI). ENT1 is very sensitive to NBTI in the low picomolar range, whereas the ENT2 transporter, with a \(K_i\) for NBTI in the micromolar range, is considered resistant (Cass et al., 1998). Based on this distinction, ENT1 was found to be responsible for ethanol inhibition of adenosine reuptake (Nagy et al., 1990; Krauss et al., 1993). Moreover, protein kinase A (PKA)-mediated phosphorylation of the ENT1 transporter and/or an associated regulatory protein might regulate the sensitivity of ENT1 to ethanol inhibition (Nagy et al., 1991; Coe et al., 1996).

Inhibition of the ENT1 transporter appears to account exclusively for the ethanol-induced increase in extracellular adenosine in cultured cells (Nagy et al., 1990; Krauss et al., 1993). It is of interest that extracellular adenosine can also be increased in tissues and organs in vivo as a consequence of ethanol metabolism in the liver (Carmichael et al., 1987, 1988, 1991; Orrego et al., 1988a). Hepatic ethanol metabolism generates acetate via the action of alcohol and acetaldehyde dehydrogenase (Orrego et al., 1988b). Acetate can be further metabolized to acetyl CoA, consuming ATP in the process, thereby generating adenosine. Adenosine released into the circulation from the liver can freely cross the blood-brain barrier (Cornford & Oldendorf, 1975), thereby increasing extracellular adenosine in the brain. In addition, a significant amount of acetate generated by alcohol metabolism in the liver is also released into the circulation where it is able to cross the blood-brain barrier. Once in the brain, acetate is readily converted to acetyl CoA, thereby generating free adenosine in situ (Berl & Frigyesi, 1969). Indeed, acetate-induced changes in CNS function appear to be mediated by adenosine because they can be prevented by adenosine receptor inhibitors (Israel et al., 1994; Campisi et al., 1997). Finally, ethanol appears to potentiate adenosine signaling in the brain directly by inhibiting adenosine uptake at synapses and cell membranes.

Extracellular adenosine activates adenosine receptors. Adenosine A1 and A3 receptors are coupled to the inhibitory G-protein Gi/o, while the adenosine A2 receptors (A2) are coupled to the stimulatory G-protein Gs or Golf (Kull et al., 2000). Therefore, the complement of adenosine receptors on specific cells will determine the response of those cells to an acute ethanol exposure. For example, acute ethanol exposure increases cAMP levels in NG108-15 cells, which express only Gs-coupled A2 (Nagy et al., 1989; Sapru et al., 1994). By contrast, hepatic cells, which express A1 receptors, exhibit a decrease in cAMP in response to acute ethanol exposure (Nagy, 1994).

## 2. Equilibrative nucleoside transporter 1

Extracellular adenosine levels are tightly regulated by the activity of nucleoside transporters, which mediate adenosine reuptake. In mammalian cells, there are 2 major classes of nucleoside transporters: sodium-dependent active transporters that drive adenosine uptake against a concentration gradient and facilitative transporters that enable adenosine to equilibrate across the membrane (Thorn & Jarvis, 1996; Cass et al., 1998; Latini & Pedata, 2001). Our studies showed that acute exposure to ethanol increases the concentration of extracellular adenosine as a result of ethanol inhibition of adenosine reuptake via a facilitative nucleoside transporter (Nagy et al., 1990; Krauss et al., 1993).

There are 2 facilitative nucleoside transporters, the equilibrative nucleoside transporters (ENT) 1 and 2. These are

## 3. cAMP/protein kinase A signaling

In NG108-15 cells and primary neurons in culture, an important consequence of ethanol-induced increases in cAMP production via A2 is the activation and translocation of PKA (Dohrman et al., 1996, 2002; Constantinescu et al.,W.S. Mailliard, I. Diamond / Pharmacology & Therapeutics 101 (2004) 39–46

PKA in turn regulates many cellular functions including cAMP-dependent cAMP response element (CRE)-mediated gene transcription (Asher et al., 2002; Yao et al., 2002). PKA is a heterodimer consisting of regulatory and catalytic subunits. PKA is activated by cAMP binding to its regulatory subunit (R), thereby causing the release of the catalytic subunit (C), which phosphorylates nearby substrates. Substrate specificity is determined largely by the subcellular localization of PKA achieved through interactions with the A kinase anchoring protein family (Lester & Scott, 1997). Therefore, we investigated the subcellular localization of the PKA after exposure to ethanol. Exposing NG108-15 cells to ethanol for 48 hr caused the PKA catalytic subunit (Ca) to dramatically alter its subcellular localization from the Golgi primarily to the nucleus (Dohrman et al., 1996). In these chronic ethanol experiments, PKA remained in the nucleus as long as ethanol was present (Dohrman et al., 1996). PKA in the nucleus was active and not regulated by cAMP (Constantinescu et al., 1999). This suggests that PKA Ca in the nucleus was not associated with R. However, PKA retention in the nucleus required RNA and protein synthesis, suggesting that ethanol increased the production of a factor that binds PKA Ca in the nucleus (Dohrman et al., 2002). It is now apparent that ethanol-induced PKA Ca translocation occurs in 2 distinct phases, an early phase and a late phase. These 2 phases are temporally distinct and independently regulated (Dohrman et al., 2002). The early phase of ethanol-induced PKA Ca translocation reaches its peak at 10 min; PKA Ca then exits the nucleus within 1 hr (Dohrman et al., 2002) only to reenter the nucleus during the late phase.

The early phase of ethanol-induced PKA Ca translocation requires an increase in extracellular adenosine and activation of A2. Thus, degradation of extracellular adenosine by adenosine deaminase or A2 blockade (Dohrman et al., 2002; Yao et al., 2002) prevents the early phase of ethanol-induced PKA Ca translocation. Moreover, the PKA inhibitor Rp-cAMP also blocks translocation confirming a requirement for PKA activation by cAMP (Dohrman et al., 2002). Acute ethanol-induced PKA Ca translocation has now been observed in several cell lines as well as in untransformed primary neuronal cultures (Dohrman et al., 2002; Yao et al., 2002). The late phase of PKA Ca translocation begins after 6 hr of exposure to ethanol and requires activation by cAMP (Constantinescu et al., 2002). However, the late phase of PKA Ca translocation does not require extracellular adenosine (Dohrman et al., 2002).

Ethanol-induced PKA Ca translocation to the nucleus in 10 min appears to have pathophysiological significance. PKA increases gene expression by phosphorylating Ser-133 on the CRE binding protein (CREB), an important molecular mechanism in memory and addiction (Berke & Hyman, 2000; Nestler, 2001). Phosphorylation of CREB initiates transcription at genes containing the CRE. Using a luciferase reporter construct under CRE control, Asher et al. (2002) found that ethanol promotes cAMP-dependent gene expression. Most importantly, an acute ethanol-induced increase in cAMP and PKA Ca translocation is followed by activation of cAMP-dependent gene expression hours after ethanol is removed (Yao et al., 2002). This observation is consistent with current concepts, which suggest that significant cAMP-dependent gene expression persists long after cAMP produced by receptor activation has been degraded (Schwartz, 2001). Indeed, these observations may help to explain the recent observation that a single dose of ethanol potentiates GABAergic synaptic function for >7 days. Potentiation is PKA-dependent and appears to contribute to increased ethanol consumption (Melis et al., 2002). Thus, persistent changes in cAMP-dependent gene expression produced by brief exposures to ethanol appear to be consistent with the pathophysiological importance of PKA in the development of addiction (Nestler, 2001).

Further analysis has revealed that ethanol-induced CREB phosphorylation and cAMP-dependent gene expression are differentially mediated by two PKA isoforms. NG108-15 cells express type II PKA consisting of RIIB-Ca and type I PKA consisting of RIB-CB (Constantinescu et al., 2002). On ethanol exposure, both subunits of type II PKA, RIIB and Ca, translocate to the nucleus where Ca phosphorylates CREB on Ser-133. By contrast, the type I PKA subunits, RIB and CB, do not translocate into the nucleus. Interestingly, type I PKA inhibition prevents ethanol-induced cAMP-dependent gene expression although it has no effect on ethanol-induced CREB phosphorylation. This indicates that in NG108-15 cells, ethanol-induced activation of CRE-mediated gene transcription requires the activation of both type I and type II isoforms of PKA (Constantinescu et al., 2002). Microarray studies also indicate that a high percentage of ethanol-responsive genes require PKA (Thibault et al., 2000; Hassan et al., 2003).

These findings suggest that ethanol-induced activation of PKA could play a critical role in changing gene expression, eventually leading to behavioral changes in ethanol sensitivity and consumption. Indeed, several in vivo studies have demonstrated a robust link between alterations in the cAMP/PKA signaling pathway and consumption of and sensitivity to ethanol (Moore et al., 1998; Park et al., 2000; Thiele et al., 2000; Pandey et al., 2001; Wand et al., 2001). Moore et al. (1998) identified a *Drosophila* mutant whose increased ethanol sensitivity appears to be due to decreased function of the cAMP/PKA signaling pathway. Similarly, mice with a targeted disruption of the stimulatory G-protein allele or with reduced neuronal PKA activity consume less alcohol and are more sensitive to the sedative effects of ethanol (Abel et al., 1997; Wand et al., 2001). In contrast, Thiele et al. (2000) reported that mice lacking the RIIB subunit of PKA consume more ethanol and are less sensitive to the sedative effects of ethanol. A *Drosophila* mutant deficient in RIIB is also less sensitive to ethanol (Park et al., 2000) and mice lacking the PKA RIB regulatory subunit showed no change in ethanol consumption or sensitivity (Thiele et al., 2000). The reason for discrepancies relating
regulatory subunit deletions with alcohol drinking behavior is unclear but may reflect differential compensation in genetically engineered animals. Nevertheless, it does seem, in general, that PKA modulates the amount of voluntary alcohol consumption, which is often inversely related to sensitivity to alcohol intoxication. This relationship is supported by genetic studies in humans, which suggest that tolerance to the acute effects of alcohol predicts the development of alcoholism years later (Schuckit, 1994).

## 4. Dopamine D2 and adenosine A2 receptors

The mesolimbic dopamine system, which includes the ventral tegmental area (VTA) and nucleus accumbens (NAc), is activated during addictive behaviors (Berke & Hyman, 2000; Hyman & Malenka, 2001). Alcohol increases the release of dopamine in the NAc from projections that originate in the VTA (Appel et al., 2003) and there is extensive evidence that dopaminergic mechanisms contribute to the reward and reinforcement of ethanol consumption (Phillips et al., 1998; Cunningham et al., 2000; Riserger et al., 2000). For example, ethanol self-administration can be increased or decreased by the microinjection of dopamine D2 receptor (D2) agonists or antagonists into the NAc (Hodge et al., 1997). An intriguing observation is that medium spiny neurons in the NAc are characterized by the coexpression of A2 with D2 on the same cells (Fink et al., 1992). In addition, these neurons express some of the highest levels of A2 in the brain (Jarvis et al., 1989; Parkinson & Fredholm, 1990; Wan et al., 1990; Martinez-Mir et al., 1991; Nonaka et al., 1994; Svenningsson et al., 1997; Fredholm et al., 1998; Rosin et al., 1998).

The relationship between A2 and D2 signaling systems is ordinarily antagonistic. Activated A2 promotes the release of Gαs, which stimulates AC activity. By contrast, activation of D2 releases Gαi, which inhibits A2-stimulated AC activity, resulting in a decrease in intracellular cAMP levels (Obadiah et al., 1999). The importance of A2/D2 antagonism has been related to the close physical association and interaction of these receptors with each other (Schiffmann et al., 1991; Ferre et al., 1993, 1994; Franco et al., 2000). We investigated the relationship of D2 to ethanol/A2 activation of PKA and CRE-mediated gene expression in cells stably expressing D2 (NG108-15/D2; Asai et al., 1998). When studied as a function of time, there was a biphasic response to the D2 agonist NPA. Thus, 50 nM NPA increased cAMP production and induced PKA Cα translocation at 10 min but decreased cAMP levels at 30 min (Yao et al., 2002). A 10-min exposure to NPA also increased cAMP-dependent gene expression 5 hr later, mimicking the response of these cells to ethanol (Yao et al., 2002). The D2 antagonist spiperone (SPIP) inhibited NPA-induced PKA activation and cAMP-dependent gene expression (Yao et al., 2002), indicating that NPA activation of cAMP/PKA signaling was receptor specific for D2.

How does activation of the Gi/o-coupled D2 increase cAMP/PKA signaling? Gi/o is a trimeric protein consisting of α and βγ dimer subunits. Gαi/o inhibits AC activity. However, released βγ dimers from Gi can potentiate cAMP production by AC isoforms II and IV (Tang & Gilman, 1991; Federman et al., 1992; Ingelse et al., 1994; Baker et al., 1999). NG108-15/D2 cells possess AC II and IV and are therefore capable of responding to βγ dimers (Yao et al., 2002). Indeed, incubation with the specific Gi/o inhibitor pertussis toxin (PTX) prevented D2 activation of PKA-mediated signaling (Yao et al., 2002), suggesting that activation of D2 and the release of βγ from Gαi/o could activate AC (Watts & Neve, 1996; Watts & Neve, 1997). This was tested directly using βγ dominant-negative inhibitor peptides, which act as scavengers by binding the free βγ dimers released from Gαi/o (Koch et al., 1994). These peptides eliminated D2 activation of cAMP/PKA signaling (Yao et al., 2002). Thus, free βγ dimers released from Gi/o appear to mediate D2-induced increases in cAMP, activation of PKA, and stimulation of cAMP-dependent gene expression. Interestingly, adenosine receptor blockade does not inhibit D2-activated cAMP production by saturating concentrations of NPA (Yao et al., 2002).

The observation that ethanol or NPA activate PKA signaling through Gαs or Gi-βγ, respectively, suggests that ethanol/A2 activation might synergize with NPA/D2 activation (Fig. 1). To search for evidence of synergy, Yao et al. (2002) selected low concentrations of NPA (0.5 nM) or ethanol (25 mM), which alone would not activate PKA signaling. However, when these subthreshold doses of ethanol and NPA were added together, there was a robust synergistic activation of PKA Cα translocation and cAMP-dependent gene expression (Yao et al., 2002). Importantly, the level of activation was similar to that seen with forskolin, a potent activator of AC activity. Furthermore, coactivation of A2 and D2 synergistically increases cAMP levels in PC-12 cells stably expressing D2 (Kudlacek et al., 2003). Synergy requires adenosine and A2 and is mediated by βγ dimers released from Gi/o (Yao et al., 2002).

Previous studies (described above) demonstrated that ethanol-induced PKA activation and cAMP-dependent gene expression depended on A2 activation. On the other hand, the adenosine receptor antagonist BW-1434U has no effect on NPA-induced PKA activation (Yao et al., 2002). By contrast, when subthreshold concentrations of ethanol or NPA are used to produce synergy, adenosine receptor blockade prevents synergistic activation of cAMP/PKA signaling and cAMP-dependent gene expression (Yao et al., 2002). As expected, PTX and βγ scavenging peptides, which inhibit the release and action of Gi-βγ dimers, respectively, also prevent synergy between ethanol/A2 and NPA/D2 (Yao et al., 2002). Taken together, these observations raise the interesting possibility that neurons, which express A2 and D2 on the same cells, like in the NAc, could be hypersensitive to exogenous ethanol due to synergy with D2 signaling. Synergy in such neurons would also be

W.S. Mailliard, I. Diamond / Pharmacology & Therapeutics 101 (2004) 39–46

## Synergy of PKA Signaling

injected directly into the NAc of rats trained to consume alcohol voluntarily. Maximal expression of the βγ inhibitor in the NAc was associated with a significant reduction in voluntary ethanol consumption. Indeed, the time course for reduced drinking corresponded directly with the time course of viral expression, recovering only when viral expression had dissipated. Importantly, βγ inhibition was specific for ethanol because βγ inhibitor expression had no effect on water consumption (Yao et al., 2002).

We propose that the postsynaptic expression of A2 and D2 on medium spiny neurons in the NAc confers hypersensitivity to exogenous ethanol while simultaneously increasing endogenous dopaminergic D2 signaling because of synergy. Synergy appears to be mediated by βγ dimers released on D2 activation of Gi. Most importantly, adenosine is required for ethanol/A2 and dopamine/D2 synergy. Adenosine mediates many responses to ethanol. Studies on the role of adenosine in ethanol-induced ataxia have implicated A1 receptors (Dar, 2001). By contrast, we speculate that A2 in the NAc appear to play a significant role in activity reward, reinforcement, and mediation of voluntary alcohol consumption. Moreover, because of the central role of the NAc in addiction and the characteristic expression of A2 and D2 on medium spiny neurons in the NAc, A2/D2 synergy might be related to drug-seeking behavior as well as voluntary alcohol consumption.

### 6. Summary and conclusions

There is substantial evidence that adenosine plays a major role in mediating neuronal responses to ethanol, which contribute to alcohol-induced ataxia and drinking behavior. Brief exposure to ethanol inhibits a specific nucleoside transporter, ENT1, leading to an increase in extracellular adenosine. Ethanol metabolism in the liver also increases adenosine in the brain. Ethanol-induced increases in extracellular adenosine activate A2, leading to Gαs-mediated increases in cAMP, activation of types I and II PKA, type II PKA Cα translocation to the nucleus, and induction of cAMP-dependent gene expression.

Ethanol and other addicting drugs all activate the NAc, a brain region shown to be involved in reinforcement and reward. There are several studies indicating that D2 activation is involved in drinking behavior. Medium spiny neurons in the NAc are characterized by the coexpression of A2 and D2 in the same cells. Results in cell culture demonstrate that neurons that coexpress A2 and D2 exhibit synergy for PKA signaling and cAMP-dependent gene expression between subthreshold concentrations of ethanol and a D2 agonist. Synergy is mediated by βγ dimers released from Gi/o and requires adenosine and A2. Expression of βγ inhibitor in the NAc reduces voluntary alcohol consumption. We propose that the coexpression of A2 and D2 in the same neurons, like in NAc, appears to render such cells hypersensitive to exogenous ethanol and endogenous D2

### 5. βγ Modulation of drinking behavior

Because ethanol activation of the NAc is associated with the release of dopamine in this brain region, Yao et al. (2002) investigated the possibility that synergy mediated by βγ dimers between ethanol/A2 and dopamine/D2 in cell culture might have pathophysiological significance in vivo. An adenoviral construct expressing the carboxyl terminus of the β adrenergic receptor kinase, βARK minigene (a gift from Dr. Robert Lefkowitz at Duke University), was

Fig. 1. Synergy of PKA signaling. Schematic representation of D2 and ethanol-induced PKA Cα translocation and CRE-mediated gene expression. A central role for Gi/o βγ subunits is proposed. D2 signaling is indicated by red arrows, and ethanol signaling is indicated by blue arrows. Ethanol (EtOH) inhibits adenosine uptake, leading to an increase in extracellular adenosine and activation of A2. This increases cAMP and activates PKA. D2 activation releases βγ dimers, which stimulate AC II and/or IV. The final common pathway includes increased cAMP levels and release of Cα from PKA. PKA Cα translocates to the nucleus, phosphorylates CREB, and increases CRE-mediated gene expression. Reprinted from Yao et al. (2002), with permission from Elsevier.

expected to confer simultaneous hypersensitivity to endogenous D2 signaling in the presence of ethanol.

dopaminergic signaling. This raises the possibility that drugs, which target βγ and/or the signaling pathways required for synergy, might be useful in preventing and treating alcoholism and alcohol abuse.

# Acknowledgments

We thank A. Constantinescu for helpful comments and S. Karadottir for expert manuscript preparation. This work was supported in part by a National Institutes of Health grant to I.D. (AA10030), funds provided by the State of California for medical research on ethanol and substance abuse through the University of California, San Francisco, and a grant from the Department of the Army, DAMD 17-01-1-0803 to I.D.

# References

Abel, T., Nguyen, P. V., Barad, M., Deuel, T. A. S., & Kandel, E. R. (1997). Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. *Cell* 88, 615–626.

Appel, S. B., Liu, Z., McElvain, M. A., & Brodie, M. S. (2003). Ethanol excitation of dopaminergic ventral tegmental area neurons is blocked by quinidine. *J Pharmacol Exp Ther* 306, 437–446.

Asai, K., Ishii, A., Yao, L., Diamond, I., & Gordon, A. S. (1998). Varying effects of ethanol on transfected cell lines. *Alcohol Clin Exp Res* 22(1), 163–166.

Asher, O., Cunningham, T. D., Yao, L., Gordon, A. S., & Diamond, I. (2002). Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase. *J Pharmacol Exp Ther* 301, 66–70.

Baker, L. P., Nielsen, M. D., Impey, S., Hacker, B. M., Poser, S. W., Chan, M. Y. M., & Storm, D. R. (1999). Regulation and immunohistochemical localization of βγ-stimulated adenylyl cyclases in mouse hippocampus. *J Neurosci* 19, 180–192.

Berke, J. D., & Hyman, S. E. (2000). Addiction, dopamine, and the molecular mechanisms of memory. *Neuron* 25, 515–532.

Berl, S., & Frigyesi, T. L. (1969). The turnover of glutamate, glutamine, aspartate and GABA labeled with [1-14C]acetate in caudate nucleus, thalamus and motor cortex (CAT). *Brain Res* 12, 444–455.

Campisi, P., Carmichael, F. J. L., Crawford, M., Orrego, H., & Khanna, J. M. (1997). Role of adenosine in the ethanol-induced potentiation of the effects of general anesthetics in rats. *Eur J Pharmacol* 325, 165–172.

Carmichael, F. J., Israel, Y., Saldivia, V., Giles, H. G., Meggiorini, S., & Orrego, H. (1987). Blood acetaldehyde and the ethanol-induced increase in splanchnic circulation. *Biochem Pharmacol* 36, 2673–2678.

Carmichael, F. J., Saldivia, V., Varghese, G. A., Israel, Y., & Orrego, H. (1988). Ethanol-induced increase in portal blood flow: role of acetate and A₁- and A₂-adenosine receptors. *Am J Physiol* 255, G417–G423.

Carmichael, F. J., Israel, Y., Crawford, M., Minhas, K., Saldivia, V., Sandrin, S., Campisi, P., & Orrego, H. (1991). Central nervous system effects of acetate: contribution to the central effects of ethanol. *J Pharmacol Exp Ther* 259, 403–408.

Cass, C. E., Young, J. D., & Baldwin, S. A. (1998). Recent advances in the molecular biology of nucleoside transporters of mammalian cells. *Biochem Cell Biol* 76, 761–770.

Charness, M. E., Querimit, L. A., & Henteleff, M. (1988). Ethanol differentially regulates G proteins in neural cells. *Biochem Biophys Res Commun* 155, 138–143.

Coe, I. R., Dohrman, D. P., Constantinescu, A., Diamond, I., & Gordon, A. S. (1996). Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol. *J Pharmacol Exp Ther* 276, 365–369.

Constantinescu, A., Diamond, I., & Gordon, A. S. (1999). Ethanol-induced translocation of cAMP-dependent protein kinase to the nucleus. Mechanism and functional consequences. *J Biol Chem* 274, 26985–26991.

Constantinescu, A., Gordon, A. S., & Diamond, I. (2002). cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression: implications for neuronal responses to ethanol. *J Biol Chem* 277, 18810–18816.

Cornford, E. M., & Oldendorf, W. H. (1975). Independent blood-brain barrier transport systems for nucleic acid precursors. *Biochim Biophys Acta* 394, 211–219.

Cunningham, C. L., Howard, M. A., Gill, S. J., Rubinstein, M., Low, M. J., & Grandy, D. K. (2000). Ethanol-conditioned place preference is reduced in dopamine D2 receptor-deficient mice. *Pharmacol Biochem Behav* 67, 693–699.

Dar, M. S. (2001). Modulation of ethanol-induced motor incoordination by mouse striatal A(1) adenosinergic receptor. *Brain Res Bull* 55, 513–520.

Diamond, I., & McIntire, S. (2002). Alcohol neurotoxicity. In A. K. Asbury, G. McKhann, W. I. McDonald, P. J. Goadsby, & J. C. McArthur (Eds.), *Diseases of the Nervous System* (pp. 1814–1826). Philadelphia: WB Saunders.

Dohrman, D. P., Diamond, I., & Gordon, A. S. (1996). Ethanol causes translocation of cAMP-dependent protein kinase catalytic subunit to the nucleus. *Proc Natl Acad Sci USA* 93, 10217–10221.

Dohrman, D. P., Chen, H. M., Gordon, A. S., & Diamond, I. (2002). Ethanol-induced translocation of protein kinase A occurs in two phases: control by different molecular mechanisms. *Alcohol Clin Exp Res* 26, 407–415.

Dunwiddie, T. V., & Masino, S. A. (2001). The role and regulation of adenosine in the central nervous system. *Annu Rev Neurosci* 24, 31–55.

Federman, A. D., Conklin, B. R., Schrader, K. A., Reed, R. R., & Bourne, H. R. (1992). Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits. *Nature* 356, 159–161.

Ferre, S., O'Connor, W. T., Fuxe, K., & Ungerstedt, U. (1993). The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. *J Neurosci* 13, 5402–5406.

Ferre, S., O'Connor, W. T., Snaprud, P., Ungerstedt, U., & Fuxe, K. (1994). Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. *Neuroscience* 63, 765–773.

Fink, J. S., Weaver, D. R., Rivkees, S. A., Peterfreund, R. A., Pollack, A. E., Adler, E. M., & Reppert, S. M. (1992). Molecular cloning of the rat A₂ adenosine receptor: selective co-expression with D₂ dopamine receptors in rat striatum. *Mol Brain Res* 14, 186–195.

Franco, R., Ferre, S., Agnati, L., Torvinen, M., Gines, S., Hillion, J., Cadaso, V., Lledo, P., Zoli, M., Lluis, C., & Fuxe, K. (2000). Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. *Neuropsychopharmacology* 23, S50–S59.

Fredholm, B. B., Lindstrom, K., Dionisotti, S., & Ongini, E. (1998). [³H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies. *J Neurochem* 70, 1210–1216.

Gordon, A. S., Collier, K., & Diamond, I. (1986). Ethanol regulation of adenosine receptor-stimulated cAMP levels in a clonal neural cell line: an in vitro model of cellular tolerance to ethanol. *Proc Natl Acad Sci USA* 83, 2105–2108.

Harper, J. F., & Brooker, G. (1980). Alcohol potentiation of isoproterenol-stimulated cyclic AMP accumulation in rat parotid. *J Cyclic Nucleotide Res* 6, 51–62.

Hassan, S., Duong, B., Kim, K.-S., & Miles, M. F. (2003). Pharmacogenomic analysis of mechanisms mediating ethanol regulation of dopamine beta-hydroxylase. *J Biol Chem* 278, 38860–38869.

Hodge, C. W., Samson, H. H., & Chappelle, A. M. (1997). Alcohol self-administration: further examination of the role of dopamine receptors in the nucleus accumbens. *Alcohol Clin Exp Res* 21, 1083–1091.

Hyman, S. E., & Malenka, R. C. (2001). Addiction and the brain: the neurobiology of compulsion and its persistence. *Nat Rev Neurosci* 2, 695–703.

Inglese, J., Luttrell, L. M., Iniguez-Lluhi, J. A., Touhara, K., Koch, W. J., & Lefkowitz, R. J. (1994). Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase. *Proc Natl Acad Sci USA* 91, 3637–3641.

Israel, Y., Orrego, H., & Carmichael, F. J. (1994). Acetate-mediated effects of ethanol. *Alcohol Clin Exp Res* 18, 144–148.

Jarvis, M. F., Jackson, R. H., & Williams, M. (1989). Autoradiographic characterization of high-affinity adenosine A₂ receptors in the rat brain. *Brain Res* 484, 111–118.

Koch, W. J., Hawes, B. E., Inglese, J., Luttrell, L. M., & Lefkowitz, R. J. (1994). Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling. *J Biol Chem* 269, 6193–6197.

Krauss, S. W., Ghimikar, R. B., Diamond, I., & Gordon, A. S. (1993). Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters. *Mol Pharmacol* 44, 1021–1026.

Kudlacek, O., Just, H., Korkhov, V. M., Varian, N., Klinger, M., Pankevych, H., Yang, Q., Nanoff, C., Freissmuth, M., & Boehm, S. (2003). The human D(2) dopamine receptor synergizes with the A(2A) adenosine receptor to stimulate adenylyl cyclase in PC12 cells. *Neuropsychopharmacology* 28, 1317–1327.

Kull, B., Svenningsson, P., & Fredholm, B. B. (2000). Adenosine A2A receptors are colocalized with and activate golf in rat striatum. *Mol Pharmacol* 58, 771–777.

Latini, S., & Pedata, F. (2001). Adenosine in the central nervous system: release mechanisms and extracellular concentrations. *J Neurochem* 79, 463–484.

Lester, L. B., & Scott, J. D. (1997). Anchoring and scaffold proteins for kinases and phosphatases. *Recent Prog Horm Res* 52, 429–430.

Martinez-Mir, M. I., Probst, A., & Palacios, J. M. (1991). Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease. *Neuroscience* 42, 697–706.

Melis, M., Camarini, R., Ungless, M. A., & Bonci, A. (2002). Long-lasting potentiation of GABA-ergic synapses in dopamine neurons after a single in vivo ethanol exposure. *J Neurosci* 22, 2074–2082.

Mochly-Rosen, D., Chang, F.-H., Cheever, L., Kim, M., Diamond, I., & Gordon, A. S. (1988). Chronic ethanol causes heterologous desensitization of receptors by reducing as messenger RNA. *Nature* 333, 848–850.

Moore, M. S., DeZazzo, J., Luk, A. Y., Tully, T., Singh, C. M., & Heberlein, U. (1998). Ethanol intoxication in *Drosophila*: genetic and pharmacological evidence for regulation by the CAMP signaling pathway. *Cell* 93, 997–1007.

Nagy, L. E. (1994). Role of adenosine A₁ receptors in inhibition of receptor-stimulated cyclic AMP production by ethanol in hepatocytes. *Biochem Pharmacol* 48, 2091–2096.

Nagy, L. E., Diamond, I., Collier, K., Lopez, L., Ullman, B., & Gordon, A. S. (1989). Adenosine is required for ethanol-induced heterologous desensitization. *Mol Pharmacol* 36, 744–748.

Nagy, L. E., Diamond, I., Casso, D. J., Franklin, C., & Gordon, A. S. (1990). Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. *J Biol Chem* 265, 1946–1951.

Nagy, L. E., Diamond, I., & Gordon, A. S. (1991). cAMP-dependent protein kinase regulates inhibition of adenosine transport by ethanol. *Mol Pharmacol* 40, 812–817.

Nestler, E. J. (2001). Molecular basis of long-term plasticity underlying addiction. *Nat Rev Neurosci* 2, 119–128.

Nonaka, H., Mori, A., Ichimura, M., Shindou, T., Yanagawa, K., Shimada, J., & Kase, H. (1994). Binding of [³H]KF17837S, a selective adenosine A₂ receptor antagonist, to rat brain membranes. *Mol Pharmacol* 46, 817–822.

Obadiah, J., Avidor-Reiss, T., Fishburn, C. S., Carmon, S., Bayewitch, M., Vogel, Z., Fuchs, S., & Levavi-Sivan, B. (1999). Adenylyl cyclase

interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs. *Cell Mol Neurobiol* 19, 653–664.

Orrego, H., Carmichael, F. J., & Israel, Y. (1988a). New insights on the mechanism of the alcohol-induced increase in portal blood flow. *Can J Pharmacol* 66, 1–9.

Orrego, H., Carmichael, F. J., Saldivia, V., Giles, H. G., Sandrin, S., & Israel, Y. (1988b). Ethanol-induced increase in portal blood flow: role of adenosine. *Am Physiol Soc*, G495–G501.

Pandey, S. C., Saito, T., Yoshimura, M., Sohma, H., & Gotz, M. E. (2001). cAMP signaling cascade: a promising role in ethanol tolerance and dependence. *Alcohol Clin Exp Res* 25, 465–588.

Park, S. K., Sedore, S. A., Cronmiller, C., & Hirsh, J. (2000). Type II cAMP-dependent protein kinase-deficient *Drosophila* are viable but show developmental, circadian, and drug response phenotypes. *J Biol Chem* 275, 20588–20596.

Parkinson, F. E., & Fredholm, B. B. (1990). Autoradiographic evidence for G-protein coupled A₂-receptors in rat neostriatum using [³H]-CGS 21680 as a ligand. *Arch Pharm* 342, 85–89.

Phillips, T. J., Brown, K. J., Burkhart-Kasch, S., Wenger, C. D., Kelly, M. A., Rubinstein, M., Grandy, D. K., & Low, M. J. (1998). Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. *Nat Neurosci* 1, 610–615.

Ribeiro, J. A., Sebastiao, A. M., & de Mendonca, A. (2003). Adenosine receptors in the nervous system: pathophysiological implications. *Prog Neurobiol* 68, 377–392.

Risinger, F. O., Freeman, P. A., Rubinstein, M., Low, M. J., & Grandy, D. K. (2000). Lack of operant ethanol self-administration in dopamine D2 receptor knockout mice. *Psychopharmacology (Berl)* 152, 343–350.

Rosin, D. L., Robeva, A., Woodard, R. L., Guyenet, P. G., & Linden, J. (1998). Immunohistochemical localization of adenosine A₂A receptors in the rat central nervous system. *J Comp Neurol* 401, 163–186.

Sapru, M. K., Diamond, I., & Gordon, A. S. (1994). Adenosine receptors mediate cellular adaptation to ethanol in NG108-15 cells. *J Pharmacol Exp Ther* 271, 542–548.

Schiffmann, S. N., Jacobs, O., & Vanderhaeghen, J.-J. (1991). Striatal restricted adenosine A₂ receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. *J Neurochem* 57, 1062–1067.

Schuckit, M. A. (1994). Alcohol sensitivity and dependence. *EXS* 71, 341–348.

Schwartz, J. H. (2001). The many dimensions of cAMP signaling. *Proc Natl Acad Sci USA* 98, 13482–13484.

Sharma, S. K., Klee, W. A., & Nirenberg, M. (1975). Dual regulation of adenylyl cyclase accounts for narcotic dependence and tolerance. *Proc Natl Acad Sci USA* 72, 3092–3096.

Svenningsson, P., Hall, H., Sedvall, G., & Fredholm, B. B. (1997). Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. *Synapse* 27, 322–335.

Tang, W. J., & Gilman, A. G. (1991). Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. *Science* 254, 1500–1503.

Thibault, C., Lai, C., Wilke, N., Duong, B., Olive, M. F., Rahman, S., Dong, H., Hodge, C. W., Lockhart, D. J., & Miles, M. F. (2000). Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression. *Mol Pharmacol* 52, 1593–1600.

Thiele, T. E., Willis, B., Stadler, J., Reynolds, J. G., Bernstein, I. L., & McKnight, G. S. (2000). High ethanol consumption and low sensitivity to ethanol-induced sedation in protein kinase A-mutant mice. *J Neurosci* 20, RC75–RC80.

Thorn, J. A., & Jarvis, S. M. (1996). Adenosine transporters. *Gen Pharmacol* 27, 613–620.

Wan, W., Sutherland, G. R., & Geiger, J. D. (1990). Binding of the adenosine A₂ receptor ligand [³H]CGS 21680 to human and rat brain: evidence for multiple affinity sites. *J Neurochem* 55, 1763–1771.

Wand, G., Levine, M., Zweifel, L., Schwindinger, W., & Abel, T. (2001). The cAMP-protein kinase A signal transduction pathway modulates ethanol consumption and sedative effects of ethanol. *J Neurosci* 21, 5297–5303.

Watts, V. J., & Neve, K. A. (1996). Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors. *Mol Pharmacol* 50, 966–976.

Watts, V. J., & Neve, K. A. (1997). Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors. *Mol Pharmacol* 52, 181–186.

Yao, L., Arolfo, M. P., Dohrman, D. P., Jiang, Z., Fan, P., Fuchs, S., Janak, P. H., Gordon, A. S., & Diamond, I. (2002). Betagamma dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. *Cell* 109, 733–743.
